Samuel W. Terman

1.6k total citations
53 papers, 980 citations indexed

About

Samuel W. Terman is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Samuel W. Terman has authored 53 papers receiving a total of 980 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Psychiatry and Mental health, 28 papers in Pediatrics, Perinatology and Child Health and 9 papers in Cellular and Molecular Neuroscience. Recurrent topics in Samuel W. Terman's work include Epilepsy research and treatment (33 papers), Pharmacological Effects and Toxicity Studies (25 papers) and Neuroscience and Neuropharmacology Research (7 papers). Samuel W. Terman is often cited by papers focused on Epilepsy research and treatment (33 papers), Pharmacological Effects and Toxicity Studies (25 papers) and Neuroscience and Neuropharmacology Research (7 papers). Samuel W. Terman collaborates with scholars based in United States, Netherlands and Switzerland. Samuel W. Terman's co-authors include Paul Park, Frank La Marca, James Burke, Timothy J. Yee, Karin M. Muraszko, Hugh Garton, Cormac O. Maher, Wajd N. Al‐Holou, Craig Kilburg and Darryl Lau and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Neurology.

In The Last Decade

Samuel W. Terman

49 papers receiving 963 citations

Peers

Countries citing papers authored by Samuel W. Terman

Since Specialization

Citations

This map shows the geographic impact of Samuel W. Terman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel W. Terman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel W. Terman more than expected).

Fields of papers citing papers by Samuel W. Terman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel W. Terman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel W. Terman. The network helps show where Samuel W. Terman may publish in the future.

Co-authorship network of co-authors of Samuel W. Terman

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel W. Terman. A scholar is included among the top collaborators of Samuel W. Terman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel W. Terman. Samuel W. Terman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Patient Perspectives on Antiseizure Medication Discontinuation 2025 ·Neurology Clinical Practice ·Samuel W. Terman, (unknown), (unknown), (unknown), A Brand, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Palak Patel, James Burke, Arthur C. Grant, Chloé E. Hill, (unknown)	2
2	Increased seizure frequency graphs in medication trials: FDA labels vs. peer-review 2025 ·Seizure ·(unknown), (unknown), (unknown), Samuel W. Terman, Daniel M. Goldenholz	0
3	Exit Strategy: Balancing the Risks and Rewards of Antiseizure Medication Withdrawal 2024 ·Epiliepsy currents ·Marian Galovic, Carolina Ferreira‐Atuesta, Lara Jehi, Kees P. J. Braun, Samuel W. Terman	2
4	Are adverse events higher among patients with acute optic neuritis prescribed glucocorticoids? A retrospective, longitudinal cohort study 2024 ·BMJ Open ·Lindsey B. De Lott, (unknown), Beth Wallace, Kevin A. Kerber, James Burke, (unknown), Samuel W. Terman, Chris Andrews, Akbar K. Waljee, Mousumi Banerjee	0
5	Development of a rapid screener to elicit patient preferences for antiseizure medication discontinuation 2024 ·Epilepsy & Behavior ·Samuel W. Terman, (unknown), (unknown), (unknown), Amanda Brand, (unknown), Neena Kalia, Margaret Dugan, (unknown), (unknown), (unknown), Palak Patel, James Burke, Arthur C. Grant, (unknown), Chloé E. Hill	2
6	Deprescribing medications among patients with multiple prescribers: A socioecological model 2023 ·Journal of the American Geriatrics Society ·(unknown), Michelle S. Keller, Jiha Lee, Hemalkumar B. Mehta, Veena Manja, (unknown), Juliessa M. Pavon, Samuel W. Terman, (unknown), Amanda S. Mixon, Amy M. Linsky	7
7	Best-worst scaling preferences among patients with well-controlled epilepsy: Pilot results 2023 ·PLoS ONE ·Samuel W. Terman, Hélène E. Aschmann, David W. Hutton, James Burke	5
8	Generalization of finetuned transformer language models to new clinical contexts 2023 ·JAMIA Open ·(unknown), Samuel W. Terman, Ryan S. Gallagher, Chloé E. Hill, Kathryn A. Davis, Brian Litt, Dan Roth, Colin A. Ellis	1
9	Frequency of and factors associated with antiseizure medication discontinuation discussions and decisions in patients with epilepsy: A multicenter retrospective chart review 2023 ·Epilepsia Open ·Samuel W. Terman, (unknown), (unknown), Jeremy Skvarce, Mellanie V. Springer, Julie Ziobro, James Burke, Willem M. Otte, Roland D. Thijs, Kees P. J. Braun	5
10	Challenges and directions in epilepsy diagnostics and therapeutics: Proceedings of the 17th Epilepsy Therapies and Diagnostics Development conference 2023 ·Epilepsia ·Samuel W. Terman, (unknown), Wesley T. Kerr, (unknown), (unknown), (unknown), (unknown), (unknown), Jacqueline A. French	9
11	Lamotrigine and exogenous estrogen among females with epilepsy: A retrospective analysis of administrative claims data 2023 ·Epilepsy & Behavior ·(unknown), Samuel W. Terman, (unknown), Page B. Pennell	1
12	HOSPITAL Score and LACE Index to Predict Mortality in Multimorbid Older Patients 2022 ·Drugs & Aging ·Carole E. Aubert, Nicolas Rodondi, Samuel W. Terman, Martin Feller, Claudio Schneider, (unknown), Olivia Dalleur, Wilma Knol, Denis O’Mahony, Drahomir Aujesky, Jacques Donzé	4
13	Development of a natural language processing algorithm to extract seizure types and frequencies from the electronic health record 2022 ·Seizure ·(unknown), (unknown), (unknown), Samuel W. Terman, (unknown), (unknown), Kathryn A. Davis, Brian Litt, Colin A. Ellis, Pouya Khankhanian, Chloé E. Hill	13
14	Cardiovascular disease risk, awareness, and treatment in people with epilepsy 2021 ·Epilepsy & Behavior ·Samuel W. Terman, Carole E. Aubert, Chloé E. Hill, Jeremy Skvarce, James Burke, Scott Mintzer	24
15	Polypharmacy in patients with epilepsy: A nationally representative cross-sectional study 2020 ·Epilepsy & Behavior ·Samuel W. Terman, Carole E. Aubert, Chloé E. Hill, Donovan T. Maust, John P. Betjemann, Cynthia M. Boyd, James Burke	21
16	The influence of age and chronic medical conditions on neurological outcomes in out of hospital cardiac arrest 2015 ·Resuscitation ·Samuel W. Terman, (unknown), (unknown), Robert Silbergleit	54
17	Impact of Presenting Rhythm on Short- and Long-Term Neurologic Outcome in Comatose Survivors of Cardiac Arrest Treated With Therapeutic Hypothermia* 2014 ·Critical Care Medicine ·Samuel W. Terman, (unknown), William J. Meurer, Robert Silbergleit	21
18	Comparison of adjacent segment disease after minimally invasive or open transforaminal lumbar interbody fusion 2014 ·Journal of Clinical Neuroscience ·Timothy J. Yee, Samuel W. Terman, Frank La Marca, Paul Park	44
19	Comparison of perioperative outcomes following open versus minimally invasive transforaminal lumbar interbody fusion in obese patients 2013 ·Neurosurgical FOCUS ·Darryl Lau, (unknown), Samuel W. Terman, Timothy J. Yee, Frank La Marca, Paul Park	58
20	Prevalence and natural history of arachnoid cysts in adults 2012 ·Journal of neurosurgery ·Wajd N. Al‐Holou, Samuel W. Terman, Craig Kilburg, Hugh Garton, Karin M. Muraszko, Cormac O. Maher	188

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact